Development Of Novel Remyelination Promoting Therapeutics For Multiple Sclerosis And Other Neurological Disorders

Project Details

StatusFinished
Effective start/end date28/03/1931/12/23

Funding

  • Pheno Therapeutics Ltd: £1,063,436.59
  • Pheno Therapeutics Ltd: £573,515.40